Company Valuation: CSPC Pharmaceutical Group Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,00,932 97,707 86,022 55,169 96,380 91,157 - -
Change - -3.19% -11.96% -35.87% 74.7% -5.42% - -
Enterprise Value (EV) 1 89,633 86,241 72,284 46,931 86,710 81,446 76,792 73,621
Change - -3.79% -16.18% -35.07% 84.76% -6.07% -5.71% -4.13%
P/E 14.7x 14.1x 13.5x 12.1x 21.8x 8.94x 13.2x 12.4x
PBR 3.17x 2.86x 2.39x 1.62x 2.56x 2.05x 1.88x 1.73x
PEG - 14.13x -1.73x -0.5x -9.88x 0x -0.4x 1.85x
Capitalization / Revenue 2.94x 2.77x 2.52x 1.78x 3.26x 2.34x 2.53x 2.37x
EV / Revenue 2.61x 2.44x 2.12x 1.51x 2.94x 2.09x 2.13x 1.92x
EV / EBITDA 9.5x 9.43x 8.39x 6.22x 12.1x 6.68x 8.05x 7.36x
EV / EBIT 10.7x 10.8x 9.77x 7.68x 15.6x 7x 9.43x 8.61x
EV / FCF 23.7x 14.1x 26.2x 17.5x 19.5x 10.8x 12.6x 12.1x
FCF Yield 4.22% 7.11% 3.82% 5.71% 5.12% 9.3% 7.94% 8.24%
Dividend per Share 2 0.18 0.21 0.28 0.26 0.29 0.4799 0.3698 0.393
Rate of return 2.13% 2.56% 3.86% 5.44% 3.44% 6.01% 4.63% 4.92%
EPS 2 0.5773 0.5831 0.5376 0.3946 0.3859 0.8933 0.6044 0.6449
Distribution rate 31.2% 36% 52.1% 65.9% 75.2% 53.7% 61.2% 60.9%
Net sales 1 34,309 35,292 34,175 31,046 29,533 39,001 35,987 38,385
EBITDA 1 9,431 9,148 8,615 7,547 7,168 12,192 9,535 9,998
EBIT 1 8,366 7,952 7,400 6,113 5,564 11,634 8,141 8,552
Net income 1 6,901 6,949 6,382 4,632 4,409 10,265 7,036 7,533
Net Debt 1 -11,298 -11,467 -13,738 -8,238 -9,670 -9,711 -14,365 -17,536
Reference price 2 8.470 8.200 7.260 4.780 8.430 7.985 7.985 7.985
Nbr of stocks (in thousands) 1,19,16,370 1,19,15,520 1,18,48,756 1,15,41,665 1,14,33,025 1,14,16,025 - -
Announcement Date 22/03/22 22/03/23 20/03/24 28/03/25 25/03/26 - - -
1HKD in Million2HKD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
8.95x2.05x5.72x5.83% 1.16TCr
41.43x14.03x29.73x0.48% 1,23200Cr
40.79x6.85x19.26x1.91% 66TCr
37.33x8.57x17.72x2.36% 51TCr
21.83x5.29x13.24x2.47% 38TCr
101.76x5.82x24.8x2.37% 34TCr
23.99x5.78x14.05x2.75% 29TCr
23.93x4.79x13.46x1.83% 28TCr
23.64x7.27x13.36x2.2% 24TCr
-40.04x7.4x46.61x1.94% 21TCr
Average 28.36x 6.78x 19.80x 2.41% 41TCr
Weighted average by Cap. 36.32x 8.79x 22.32x 1.71%

Y-o-Y evolution of P/E

Valuation ratios - P/E - CSPC Pharmaceutical Group Limited

Historical PBR trend

Valuation ratios - PBR - CSPC Pharmaceutical Group Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - CSPC Pharmaceutical Group Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - CSPC Pharmaceutical Group Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - CSPC Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 1093 Stock
  4. Valuation CSPC Pharmaceutical Group Limited